Your email has been successfully added to our mailing list.

×
0.00102392757059712 0.00102392757059712 0.00237120068980382 -0.00167061866781628 -0.00288316447510237 -0.00665552920888127 0.0144966587626643 0.00102392757059712
Stock impact report

Clover Health started at neutral by UBS, improving operations cited [Seeking Alpha]

Clover Health Investments, Corp. - Class A Common stock (CLOV) 
Company Research Source: Seeking Alpha
UBS said Clover's improved Medicare Advantage Star rating also gives it “increasing confidence” on improving MA enrollment and top-line growth, along with increased quality bonus payments. “All-in, this allows for CLOV to accelerate growth, if so desired, while maintaining reasonable economics,” UBS added. The investment bank set its price target at $4. More on Clover Health Clover Health: Changing Business Model, Seeking Profitability Clover Health: A Profitable Future Ahead Fueled By AI And Star Rating Success Clover Health Investments, Corp. (CLOV) Q2 2024 Earnings Call Transcript Hedge funds pile into healthcare stocks amid dip, Goldman Sachs says Clover Health names Joseph Brand as COO for Medicare Advantage Recommended For You Comments More Trending News Recommended For You More Trending News Show less Read more
Impact Snapshot
Event Time:
CLOV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CLOV alerts
Opt-in for
CLOV alerts

from News Quantified
Opt-in for
CLOV alerts

from News Quantified